Tackling antimicrobial resistance: why now and what next?
Antimicrobial resistance (AMR) is a clear and growing threat to health. Antibiotics are the cornerstone of modern medicine, but AMR has implications for the effective treatment of an increasing range of infections, with potential consequences for the future of health services not just in the UK but across the world.
This free online event from the King's Fund will provide an opportunity to discuss why AMR matters, the impact of the UK’s approach to tackling it so far, and what more needs to be done.
This event takes place in the context of the government’s 20-year vision for antimicrobial resistance and ongoing work to develop the upcoming 2024–29 national action plan for AMR as the current action plan comes to an end.
This panel discussion will bring together experts to discuss:
past and current efforts to tackle AMR in the UK and their impact – such as supporting the optimisation of antibiotic prescribing, developing new antibiotics, and improving the pipeline, and maximising the use of diagnostics
the impact UK actions can have on a global issue such as AMR and stewardship at an international level
what more should the UK be doing, how to understand the barriers that prevent effective action, and the levers that are available to drive progress as the UK moves into the next phase of the 20-year vision for AMR?